ライフサイエンスコーパス: red blood cell transfusion

1 nd 1 had more than a 50% reduction in packed red blood cell transfusions).

2 The exposure of interest was route of red blood cell transfusion.

3 Major gastrointestinal surgery and packed red blood cell transfusion.

4 During the study, 6 patients received >/=1 red blood cell transfusion.

5 Guidelines recommend restrictive red blood cell transfusion.

6 atients who did and did not receive a packed red blood cell transfusion.

7 ansfusion thresholds and recommendations for red blood cell transfusion.

8 s predicted the probability of perioperative red blood cell transfusion.

9 we modeled the probability of perioperative red blood cell transfusion.

10 ession was used to adjust the odds ratio for red blood cell transfusion.

11 , 21 of 61 patients (34%) no longer required red blood cell transfusions.

12 f they are not treated with exogenous Trf or red blood cell transfusions.

13 with sickle cell disease who receive chronic red blood cell transfusions.

14 fever, days of hospitalization, or number of red blood cell transfusions.

15 ve autologous erythrocyte volume to minimize red blood cell transfusions.

16 op anemia and frequently become dependent on red blood cell transfusions.

17 ed ischemic time and number of perioperative red blood cell transfusions.

18 ments during the assessment period or needed red blood cell transfusions.

19 the 2,085 patients enrolled, 21.5% received red blood cell transfusions.

20 tically ill and results in a large number of red blood cell transfusions.

21 erythropoietin to reduce the need for packed red blood cell transfusions.

22 incidence of bleeding or hematoma requiring red blood cell transfusions (0.9% versus 1.5%; odds rati

23 ation [11.0; (5.52-21.7)] and mean number of red blood cell transfusions [1.97; (0.98-3.99)].

24 12.1% vs. 8.8%), stroke (1.1% vs. 0.8%), and red blood cell transfusion (17.2% vs. 13.2%), but after

25 pidogrel, without significant differences in red blood cell transfusion (2.1 U vs. 1.7 U; p = 0.442)

26 tion [2.87; (1.40-5.90)], and mean number of red blood cell transfusions [2.72; (1.33-5.58)].

27 ively, the elderly had a higher incidence of red blood cell transfusion (28.8% versus 9.0%; P = 0.001

28 in dobutamine use (14% vs. 4%, p = .06) and red blood cell transfusions (30% vs. 18%, p = .07) in th

29 t difference was noted in the rate of packed red blood cell transfusion (6.9% vs 12.7%, respectively;

30 the percentage of patients receiving packed red blood cell transfusion (72.6 vs. 51.6%, p =.007), th

31 A patient with asplenia and multiple red blood cell transfusions acquired babesiosis infectio

32 complication, controlling for the effect of red blood cell transfusion, Acute Physiology and Chronic

33 The trial intervention reduced rates of red blood cell transfusion (adjusted relative risk, 0.91

34 For male recipients of red blood cell transfusions, all-cause mortality rates a

35 f anemia that orders were written for packed red blood cell transfusions, although only 6 patients we

36 Studies have shown variation in the use of red blood cell transfusion among patients with acute cor

37 only marginally significant (P = 0.079), and red blood cell transfusion and atrial fibrillation are t

38 he duration of CPB (TCPB) and on-pump packed red blood cell transfusions and 2) to quantify the impac

39 CPB is prolonged with intraoperative packed red blood cell transfusions and in patients with borderl

40 erature to determine the association between red blood cell transfusion, and morbidity and mortality

41 llness, clinical grade of hemorrhage, packed red blood cell transfusions, and severe sepsis in the in

42 vational studies that liberal thresholds for red blood cell transfusion are associated with a substan

43 Current guidelines for red blood cell transfusion are based on expert opinion a

44 Red blood cell transfusion can both benefit and harm.

45 Chronic red blood cell transfusion can prevent many of the manif

46 f Blood, Bernaudin et al report that chronic red blood cell transfusions can be safely replaced with

47 ohort studies in cardiac surgery showed that red blood cell transfusion compared with no transfusion

48 vational studies that assessed the effect of red blood cell transfusion compared with no transfusion

49 Corticosteroids and lenalidomide decrease red blood cell transfusion dependence in patients with D

50 In multivariable analyses, genetic score, red blood cell transfusion dependency, white blood cell

51 ase, 16, 000 to 110,000/microL), and 5 of 15 red blood cell transfusion-dependent patients had a 50%

52 nificant reduction in exposure to allogeneic red blood cell transfusion during the initial 42 days of

53 ncy (defined as having received at least one red blood cell transfusion every 8 weeks over a period o

54 42-77] years; 52% female) who received 59320 red blood cell transfusions exclusively from 1 of 3 type

55 the no-donor-mixture cohort (ie, either all red blood cell transfusions exclusively from male donors

56 tivity or disease who were receiving a first red blood cell transfusion for anemia.

57 nsfusions, all-cause mortality rates after a red blood cell transfusion from an ever-pregnant female

58 To quantify the association between red blood cell transfusion from female donors with and w

59 The primary outcome was red blood cell transfusion from surgery to postoperative

60 Red blood cell transfusions from ever-pregnant or never-

61 never-pregnant female donors, compared with red blood cell transfusions from male donors.

62 years, intraoperative requirement of packed red blood cell transfusion greater than 30 units, and pe

63 variate analyses demonstrated intraoperative red blood cell transfusion greater than 70 mL/kg (P=0.01

64 Although concern over the risks of red blood cell transfusion has resulted in several pract

65 Red blood cell transfusions have reduced morbidity and m

66 usion of fresh human red blood cells, stored red blood cell transfusion in mice decreased blood oxyge

67 Red blood cell transfusion in patients having cardiac su

68 sed the effect of liberal versus restrictive red blood cell transfusion in patients undergoing cardia

69 ictive transfusion strategy of administering red blood cell transfusion in patients with hemoglobin c

70 Most studies of HLA sensitization after red blood cell transfusion in transplant candidates were

71 se a 10 g/dL hemoglobin threshold for packed red blood cell transfusion in unstable patients (shock o

72 verse clinical outcomes when used to trigger red blood cell transfusions in anemic patients in critic

73 Recent data have shown that red blood cell transfusions in critically ill patients c

74 udy compared leukocyte-reduced to unfiltered red blood cell transfusions in human immunodeficiency vi

75 hematopoietic response, reduces the need for red blood cell transfusions, increases hemoglobin levels

76 They achieved platelet and red blood cell transfusion independence earlier, require

77 There were no significant differences for red blood cell transfusion independence, the incidence o

78 Perioperative red blood cell transfusion is the single factor most rel

79 7 mg/dL, so a more conservative approach to red blood cell transfusion is warranted.

80 Avoiding the unnecessary use of packed red blood cell transfusions may decrease the occurrence

81 84, patients receiving rHuEPO received fewer red blood cell transfusions (median units per patient 0

82 Among female recipients of red blood cell transfusions, mortality rates for an ever

83 dL), and 3) worse with intraoperative packed red blood cell transfusions (n = 385; 21.9%), in compari

84 act data demonstrated an association between red blood cell transfusions, nosocomial infections, and

85 nalysis showed that increased requirement of red blood cell transfusion (odds ratio [OR] 2.7-8.8, P<0

86 endent factors for severe complications were red blood cell transfusion [odds ratio (OR), 5.2), ALPPS

87 nsfusion burden patients, and a reduction in red blood cell transfusion of 4 or more red blood cell u

88 fect of prophylactic compared with on-demand red blood cell transfusions on maternal and neonatal out

89 tudies assessing the effects of prophylactic red blood cell transfusions on these outcomes have drawn

90 torage age of red blood cells, and number of red blood cell transfusions, only the number of transfus

91 multiorgan dysfunction after either massive red blood cell transfusion or hemoglobin-based blood sub

92 atients with greater requirements for packed red blood cell transfusions or reduced urine production

93 in patients who did not receive concomitant red blood cell transfusion (p < .01), but this associati

94 2 patients had greater intraoperative packed red blood cell transfusion (P = 0.002), and longer inten

95 e (P<0.007), RCP time (P<0.0001), and packed red blood cell transfusions (P=0.0001).

96 ypass time >120 minutes (P<0.04), and packed red blood cell transfusions (P=0.0002).

97 Despite receiving fewer red blood cell transfusions, patients treated with rHuEP

98 Available treatment options include red blood cell transfusions, pharmacologic interventions

99 an integrated transfusion algorithm reduces red blood cell transfusions, platelet transfusions, and

100 Our primary outcomes were total blood loss, red blood cell transfusion rates and amounts, reexplorat

101 patient 0 vs. 2, p = .05), and the ratio of red blood cell transfusion rates per day alive was 0.61

102 are warranted before a high plasma to packed red blood cell transfusion ratio can be recommended.

103 survival benefit with a 1:1 plasma to packed red blood cell transfusion ratio compared with either hi

104 erning the effects of a 1:1 plasma to packed red blood cell transfusion ratio.

105 Among patients who received red blood cell transfusions, receipt of a transfusion fr

106 risk of nosocomial infection associated with red blood cell transfusions remained statistically signi

107 Supportive care--primarily red blood cell transfusions--remains an important compon

108 951), nor did it significantly reduce packed red blood cell transfusion requirements in either primar

109 TXA appears effective in reducing red blood cell transfusion requirements without increasi

110 including multiorgan system failure, packed red blood cell transfusion, respiratory outcomes, and co

111 ean corpuscular volume, blood urea nitrogen, red blood cell transfusion, sepsis, and creatinine.

112 ollowing resolution of tissue hypoperfusion, red blood cell transfusion should be targeted to maintai

113 Red blood cell transfusions should be used sparingly, be

114 Four subjects who received chronic red blood cell transfusion showed improved metabolic and

115 In addition, alternatives to red blood cell transfusion, specifically red blood cell

116 DATION 1: ACP recommends using a restrictive red blood cell transfusion strategy (trigger hemoglobin

117 rvival advantage with a 1:1 plasma to packed red blood cell transfusion strategy.

118 13 000/muL), and had anaemia with or without red blood cell transfusion support.

119 atibility testing is to prevent incompatible red blood cell transfusions that could lead to immune me

120 Red-blood-cell transfusion, the most common preventive m

121 s were the percent of patients receiving any red blood cell transfusion; the percent of patients aliv

122 Of 788 patients who received a red blood cell transfusion through a multi-lumen PICC, 6

123 We assessed whether red blood cell transfusion through peripherally inserted

124 The most anemic patients require regular red blood cell transfusions to avoid death from cardiac

125 a-thalassemia major require regular lifelong Red Blood Cell transfusions to survive.

126 Packed red blood cell transfusion was associated with an increa

127 Packed red blood cell transfusion was associated with ARDS (ORa

128 enters, patients receiving at least 1 packed red blood cell transfusion were compared with those who

129 nine, increased central venous pressure, and red blood cell transfusion were factors associated with

130 Packed red blood cell transfusions were associated with increas

131 Lower serum sodium and more red blood cell transfusions were associated with intraop

132 Non-red blood cell transfusions were more common in aspirin

133 ent for at least 28 days who either required red blood cell transfusions while on ruxolitinib or ruxo

134 an with severe neutropenia and dependency on red blood cell transfusions who had previously undergone